Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc. GDNSF Peers
See (GDNSF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GDNSF | $0.45 | N/A | 61M | -2.66 | -$0.17 | N/A |
| CHALF | $0.38 | +3799900.00% | 441.8B | -4.75 | -$0.08 | N/A |
| STMH | $0.10 | +99900.00% | 126.4B | -0.05 | -$1.89 | N/A |
| THCBF | $0.02 | +2350.00% | 59B | -2.45 | -$0.01 | N/A |
| MKKGY | $26.53 | +0.57% | 58.2B | 17.81 | $1.49 | +2.18% |
| MKGAF | $130.20 | -1.36% | 56.6B | 17.62 | $7.39 | +1.66% |
| TKPHF | $32.13 | +13.65% | 50.6B | 68.36 | $0.47 | +4.14% |
| HLNCF | $5.44 | +3.30% | 48.9B | 25.90 | $0.21 | +2.01% |
| KHRNF | $0.01 | +79900.00% | 42.2B | -0.80 | -$0.01 | N/A |
| IPSEY | $30.11 | +0.89% | 39.8B | 24.68 | $1.22 | +0.74% |
Stock Comparison
GDNSF vs CHALF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CHALF has a market cap of 441.8B. Regarding current trading prices, GDNSF is priced at $0.45, while CHALF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CHALF's P/E ratio is -4.75. In terms of profitability, GDNSF's ROE is -1.54%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs STMH Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, STMH has a market cap of 126.4B. Regarding current trading prices, GDNSF is priced at $0.45, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas STMH's P/E ratio is -0.05. In terms of profitability, GDNSF's ROE is -1.54%, compared to STMH's ROE of -2.75%. Regarding short-term risk, GDNSF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs THCBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, THCBF has a market cap of 59B. Regarding current trading prices, GDNSF is priced at $0.45, while THCBF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas THCBF's P/E ratio is -2.45. In terms of profitability, GDNSF's ROE is -1.54%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, GDNSF and THCBF have similar daily volatility (0.00).
GDNSF vs MKKGY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MKKGY has a market cap of 58.2B. Regarding current trading prices, GDNSF is priced at $0.45, while MKKGY trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MKKGY's P/E ratio is 17.81. In terms of profitability, GDNSF's ROE is -1.54%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, GDNSF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs MKGAF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MKGAF has a market cap of 56.6B. Regarding current trading prices, GDNSF is priced at $0.45, while MKGAF trades at $130.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MKGAF's P/E ratio is 17.62. In terms of profitability, GDNSF's ROE is -1.54%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, GDNSF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs TKPHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TKPHF has a market cap of 50.6B. Regarding current trading prices, GDNSF is priced at $0.45, while TKPHF trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TKPHF's P/E ratio is 68.36. In terms of profitability, GDNSF's ROE is -1.54%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, GDNSF and TKPHF have similar daily volatility (0.00).
GDNSF vs HLNCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLNCF has a market cap of 48.9B. Regarding current trading prices, GDNSF is priced at $0.45, while HLNCF trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLNCF's P/E ratio is 25.90. In terms of profitability, GDNSF's ROE is -1.54%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, GDNSF and HLNCF have similar daily volatility (0.00).
GDNSF vs KHRNF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KHRNF has a market cap of 42.2B. Regarding current trading prices, GDNSF is priced at $0.45, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, GDNSF's ROE is -1.54%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, GDNSF is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs IPSEY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IPSEY has a market cap of 39.8B. Regarding current trading prices, GDNSF is priced at $0.45, while IPSEY trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IPSEY's P/E ratio is 24.68. In terms of profitability, GDNSF's ROE is -1.54%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, GDNSF and IPSEY have similar daily volatility (0.00).
GDNSF vs EVRRF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, EVRRF has a market cap of 25.7B. Regarding current trading prices, GDNSF is priced at $0.45, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, GDNSF's ROE is -1.54%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, GDNSF is less volatile compared to EVRRF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SDZNY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SDZNY has a market cap of 22.5B. Regarding current trading prices, GDNSF is priced at $0.45, while SDZNY trades at $52.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SDZNY's P/E ratio is -2609.75. In terms of profitability, GDNSF's ROE is -1.54%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SRUTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SRUTF has a market cap of 19.8B. Regarding current trading prices, GDNSF is priced at $0.45, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, GDNSF's ROE is -1.54%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, GDNSF is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs TEVJF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TEVJF has a market cap of 17.9B. Regarding current trading prices, GDNSF is priced at $0.45, while TEVJF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TEVJF's P/E ratio is -13.55. In terms of profitability, GDNSF's ROE is -1.54%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, GDNSF and TEVJF have similar daily volatility (0.00).
GDNSF vs ESALY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GDNSF is priced at $0.45, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GDNSF's ROE is -1.54%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GDNSF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SGIOY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGIOY has a market cap of 14.7B. Regarding current trading prices, GDNSF is priced at $0.45, while SGIOY trades at $8.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGIOY's P/E ratio is 12.54. In terms of profitability, GDNSF's ROE is -1.54%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, GDNSF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SGIOF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGIOF has a market cap of 14B. Regarding current trading prices, GDNSF is priced at $0.45, while SGIOF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGIOF's P/E ratio is 11.92. In terms of profitability, GDNSF's ROE is -1.54%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, GDNSF and SGIOF have similar daily volatility (0.00).
GDNSF vs IPSEF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, GDNSF is priced at $0.45, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IPSEF's P/E ratio is 25.74. In terms of profitability, GDNSF's ROE is -1.54%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, GDNSF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs RDDTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, RDDTF has a market cap of 9.8B. Regarding current trading prices, GDNSF is priced at $0.45, while RDDTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to RDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs BIOVF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, GDNSF is priced at $0.45, while BIOVF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BIOVF's P/E ratio is 22.69. In terms of profitability, GDNSF's ROE is -1.54%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, GDNSF and BIOVF have similar daily volatility (0.00).
GDNSF vs NOBDF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, GDNSF is priced at $0.45, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NOBDF's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -1.54%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, GDNSF is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs ESALF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESALF has a market cap of 8.4B. Regarding current trading prices, GDNSF is priced at $0.45, while ESALF trades at $29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESALF's P/E ratio is 26.41. In terms of profitability, GDNSF's ROE is -1.54%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, GDNSF and ESALF have similar daily volatility (0.00).
GDNSF vs SFOSF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, GDNSF is priced at $0.45, while SFOSF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SFOSF's P/E ratio is 13.40. In terms of profitability, GDNSF's ROE is -1.54%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, GDNSF and SFOSF have similar daily volatility (0.00).
GDNSF vs ESAIY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESAIY has a market cap of 7.9B. Regarding current trading prices, GDNSF is priced at $0.45, while ESAIY trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESAIY's P/E ratio is 24.80. In terms of profitability, GDNSF's ROE is -1.54%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, GDNSF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs HKMPY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, GDNSF is priced at $0.45, while HKMPY trades at $56.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HKMPY's P/E ratio is 17.66. In terms of profitability, GDNSF's ROE is -1.54%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, GDNSF and HKMPY have similar daily volatility (0.00).
GDNSF vs GZPHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GZPHF has a market cap of 6.1B. Regarding current trading prices, GDNSF is priced at $0.45, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, GDNSF's ROE is -1.54%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, GDNSF and GZPHF have similar daily volatility (0.00).
GDNSF vs HKMPF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, GDNSF is priced at $0.45, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, GDNSF and HKMPF have similar daily volatility (0.00).
GDNSF vs HLUBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLUBF has a market cap of 5.3B. Regarding current trading prices, GDNSF is priced at $0.45, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLUBF's P/E ratio is 10.65. In terms of profitability, GDNSF's ROE is -1.54%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, GDNSF and HLUBF have similar daily volatility (0.00).
GDNSF vs HLBBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, GDNSF is priced at $0.45, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLBBF's P/E ratio is 12.45. In terms of profitability, GDNSF's ROE is -1.54%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, GDNSF and HLBBF have similar daily volatility (0.00).
GDNSF vs APNHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, GDNSF is priced at $0.45, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas APNHF's P/E ratio is 16.14. In terms of profitability, GDNSF's ROE is -1.54%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, GDNSF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs LVZPF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LVZPF has a market cap of 4.1B. Regarding current trading prices, GDNSF is priced at $0.45, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, GDNSF's ROE is -1.54%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, GDNSF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs HYPMY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, GDNSF is priced at $0.45, while HYPMY trades at $4.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HYPMY's P/E ratio is 21.48. In terms of profitability, GDNSF's ROE is -1.54%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, GDNSF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs INVVY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GDNSF is priced at $0.45, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GDNSF's ROE is -1.54%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, GDNSF and INVVY have similar daily volatility (0.00).
GDNSF vs APNHY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, GDNSF is priced at $0.45, while APNHY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas APNHY's P/E ratio is 11.68. In terms of profitability, GDNSF's ROE is -1.54%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, GDNSF and APNHY have similar daily volatility (0.00).
GDNSF vs IZQVF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GDNSF is priced at $0.45, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GDNSF's ROE is -1.54%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, GDNSF and IZQVF have similar daily volatility (0.00).
GDNSF vs WIBFF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, WIBFF has a market cap of 2.9B. Regarding current trading prices, GDNSF is priced at $0.45, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, GDNSF's ROE is -1.54%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs ULIHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, GDNSF is priced at $0.45, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, GDNSF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs HMDCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, GDNSF is priced at $0.45, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, GDNSF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SHEZF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SHEZF has a market cap of 2.4B. Regarding current trading prices, GDNSF is priced at $0.45, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, GDNSF's ROE is -1.54%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, GDNSF and SHEZF have similar daily volatility (0.00).
GDNSF vs HTSUF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, GDNSF is priced at $0.45, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HTSUF's P/E ratio is 16.10. In terms of profitability, GDNSF's ROE is -1.54%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, GDNSF and HTSUF have similar daily volatility (0.00).
GDNSF vs DNPUF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, DNPUF has a market cap of 2.3B. Regarding current trading prices, GDNSF is priced at $0.45, while DNPUF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas DNPUF's P/E ratio is 14.15. In terms of profitability, GDNSF's ROE is -1.54%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, GDNSF and DNPUF have similar daily volatility (0.00).
GDNSF vs CHSYF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, GDNSF is priced at $0.45, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, GDNSF's ROE is -1.54%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, GDNSF and CHSYF have similar daily volatility (0.00).
GDNSF vs TSMRF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, GDNSF's ROE is -1.54%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, GDNSF and TSMRF have similar daily volatility (0.00).
GDNSF vs DMPHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas DMPHF's P/E ratio is 18.06. In terms of profitability, GDNSF's ROE is -1.54%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, GDNSF and DMPHF have similar daily volatility (0.00).
GDNSF vs LBTSF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LBTSF's P/E ratio is 162.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, GDNSF and LBTSF have similar daily volatility (0.00).
GDNSF vs LJUIF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, GDNSF's ROE is -1.54%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, GDNSF and LJUIF have similar daily volatility (0.00).
GDNSF vs ARSUF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, GDNSF is priced at $0.45, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, GDNSF's ROE is -1.54%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, GDNSF and ARSUF have similar daily volatility (0.00).
GDNSF vs NPNKF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NPNKF has a market cap of 1.8B. Regarding current trading prices, GDNSF is priced at $0.45, while NPNKF trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NPNKF's P/E ratio is 7.81. In terms of profitability, GDNSF's ROE is -1.54%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, GDNSF and NPNKF have similar daily volatility (0.00).
GDNSF vs CHIZF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CHIZF has a market cap of 1.7B. Regarding current trading prices, GDNSF is priced at $0.45, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, GDNSF's ROE is -1.54%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, GDNSF and CHIZF have similar daily volatility (0.00).
GDNSF vs NPPNY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NPPNY has a market cap of 1.7B. Regarding current trading prices, GDNSF is priced at $0.45, while NPPNY trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NPPNY's P/E ratio is 7.36. In terms of profitability, GDNSF's ROE is -1.54%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, GDNSF and NPPNY have similar daily volatility (0.00).
GDNSF vs EVOTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, GDNSF's ROE is -1.54%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, GDNSF and EVOTF have similar daily volatility (0.00).
GDNSF vs SMDPY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, GDNSF's ROE is -1.54%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, GDNSF and SMDPY have similar daily volatility (0.00).
GDNSF vs MITPF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GDNSF's ROE is -1.54%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, GDNSF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs YIHCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, GDNSF and YIHCF have similar daily volatility (0.00).
GDNSF vs KARBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GDNSF is priced at $0.45, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to KARBF's ROE of N/A. Regarding short-term risk, GDNSF and KARBF have similar daily volatility (0.00).
GDNSF vs TWAPF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, GDNSF is priced at $0.45, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TWAPF's P/E ratio is 9.52. In terms of profitability, GDNSF's ROE is -1.54%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, GDNSF and TWAPF have similar daily volatility (0.00).
GDNSF vs GTBIF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, GDNSF is priced at $0.45, while GTBIF trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GTBIF's P/E ratio is 23.67. In terms of profitability, GDNSF's ROE is -1.54%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, GDNSF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CASBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CASBF has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CASBF's P/E ratio is -17.81. In terms of profitability, GDNSF's ROE is -1.54%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, GDNSF and CASBF have similar daily volatility (0.00).
GDNSF vs SWGHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, GDNSF's ROE is -1.54%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, GDNSF and SWGHF have similar daily volatility (0.00).
GDNSF vs GNMLF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GNMLF's P/E ratio is 9.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, GDNSF and GNMLF have similar daily volatility (0.00).
GDNSF vs SHPHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, GDNSF's ROE is -1.54%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, GDNSF and SHPHF have similar daily volatility (0.00).
GDNSF vs KSPHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KSPHF has a market cap of 1B. Regarding current trading prices, GDNSF is priced at $0.45, while KSPHF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KSPHF's P/E ratio is 12.62. In terms of profitability, GDNSF's ROE is -1.54%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, GDNSF and KSPHF have similar daily volatility (0.00).
GDNSF vs KKPCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KKPCF has a market cap of 980.3M. Regarding current trading prices, GDNSF is priced at $0.45, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KKPCF's P/E ratio is 10.54. In terms of profitability, GDNSF's ROE is -1.54%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, GDNSF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs BIOGY Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, GDNSF is priced at $0.45, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BIOGY's P/E ratio is 30.47. In terms of profitability, GDNSF's ROE is -1.54%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, GDNSF and BIOGY have similar daily volatility (0.00).
GDNSF vs NRXCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NRXCF has a market cap of 853.3M. Regarding current trading prices, GDNSF is priced at $0.45, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, GDNSF's ROE is -1.54%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, GDNSF and NRXCF have similar daily volatility (0.00).
GDNSF vs CSWYF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, GDNSF is priced at $0.45, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, GDNSF's ROE is -1.54%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, GDNSF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs ELTP Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ELTP has a market cap of 781.7M. Regarding current trading prices, GDNSF is priced at $0.45, while ELTP trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ELTP's P/E ratio is -36.58. In terms of profitability, GDNSF's ROE is -1.54%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, GDNSF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs AGYTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, GDNSF is priced at $0.45, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, GDNSF's ROE is -1.54%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, GDNSF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs NIKA Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, GDNSF is priced at $0.45, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NIKA's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -1.54%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, GDNSF and NIKA have similar daily volatility (0.00).
GDNSF vs TCNNF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TCNNF has a market cap of 697.9M. Regarding current trading prices, GDNSF is priced at $0.45, while TCNNF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TCNNF's P/E ratio is -4.62. In terms of profitability, GDNSF's ROE is -1.54%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, GDNSF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs TRXPF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GDNSF is priced at $0.45, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GDNSF's ROE is -1.54%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, GDNSF and TRXPF have similar daily volatility (0.00).
GDNSF vs ABSCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ABSCF has a market cap of 682.7M. Regarding current trading prices, GDNSF is priced at $0.45, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, GDNSF's ROE is -1.54%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, GDNSF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SWDCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, GDNSF is priced at $0.45, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, GDNSF's ROE is -1.54%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GDNSF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs LVTTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LVTTF has a market cap of 664.6M. Regarding current trading prices, GDNSF is priced at $0.45, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, GDNSF's ROE is -1.54%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CURLF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CURLF has a market cap of 638.4M. Regarding current trading prices, GDNSF is priced at $0.45, while CURLF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CURLF's P/E ratio is -2.55. In terms of profitability, GDNSF's ROE is -1.54%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, GDNSF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs BOIRF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, GDNSF is priced at $0.45, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, GDNSF's ROE is -1.54%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, GDNSF and BOIRF have similar daily volatility (0.00).
GDNSF vs TRSSF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GDNSF is priced at $0.45, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GDNSF's ROE is -1.54%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, GDNSF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs MNFSF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, GDNSF is priced at $0.45, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, GDNSF's ROE is -1.54%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, GDNSF is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs SGFEF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGFEF has a market cap of 536.8M. Regarding current trading prices, GDNSF is priced at $0.45, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, GDNSF's ROE is -1.54%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, GDNSF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CCHWF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GDNSF is priced at $0.45, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GDNSF's ROE is -1.54%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, GDNSF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs AIHLF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, GDNSF is priced at $0.45, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, GDNSF's ROE is -1.54%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GDNSF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs PEXXF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GDNSF is priced at $0.45, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GDNSF and PEXXF have similar daily volatility (0.00).
GDNSF vs KHTRF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KHTRF has a market cap of 439.4M. Regarding current trading prices, GDNSF is priced at $0.45, while KHTRF trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KHTRF's P/E ratio is 63.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, GDNSF and KHTRF have similar daily volatility (0.00).
GDNSF vs LRDSF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LRDSF has a market cap of 381.9M. Regarding current trading prices, GDNSF is priced at $0.45, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, GDNSF's ROE is -1.54%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, GDNSF and LRDSF have similar daily volatility (0.00).
GDNSF vs EOFBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, EOFBF has a market cap of 333.2M. Regarding current trading prices, GDNSF is priced at $0.45, while EOFBF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas EOFBF's P/E ratio is -2.33. In terms of profitability, GDNSF's ROE is -1.54%, compared to EOFBF's ROE of -1.26%. Regarding short-term risk, GDNSF and EOFBF have similar daily volatility (0.00).
GDNSF vs BHCCF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, GDNSF is priced at $0.45, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, GDNSF's ROE is -1.54%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, GDNSF and BHCCF have similar daily volatility (0.00).
GDNSF vs BHHKF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BHHKF has a market cap of 293M. Regarding current trading prices, GDNSF is priced at $0.45, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, GDNSF's ROE is -1.54%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, GDNSF is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs PKBFF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PKBFF has a market cap of 292.3M. Regarding current trading prices, GDNSF is priced at $0.45, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GDNSF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs ABTI Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ABTI has a market cap of 291.9M. Regarding current trading prices, GDNSF is priced at $0.45, while ABTI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ABTI's P/E ratio is -20.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, GDNSF and ABTI have similar daily volatility (0.00).
GDNSF vs GLASF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GLASF has a market cap of 279.5M. Regarding current trading prices, GDNSF is priced at $0.45, while GLASF trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GLASF's P/E ratio is -57.11. In terms of profitability, GDNSF's ROE is -1.54%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CPHRF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CPHRF has a market cap of 253.7M. Regarding current trading prices, GDNSF is priced at $0.45, while CPHRF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CPHRF's P/E ratio is 27.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, GDNSF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs PSIQ Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, GDNSF is priced at $0.45, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PSIQ's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -1.54%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, GDNSF is less volatile compared to PSIQ. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs PLNHF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GDNSF is priced at $0.45, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, GDNSF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs VRNOF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, VRNOF has a market cap of 180.1M. Regarding current trading prices, GDNSF is priced at $0.45, while VRNOF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas VRNOF's P/E ratio is -0.50. In terms of profitability, GDNSF's ROE is -1.54%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, GDNSF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs YOURF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, YOURF has a market cap of 178.2M. Regarding current trading prices, GDNSF is priced at $0.45, while YOURF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas YOURF's P/E ratio is 0.01. In terms of profitability, GDNSF's ROE is -1.54%, compared to YOURF's ROE of +0.00%. Regarding short-term risk, GDNSF is less volatile compared to YOURF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs WLDFF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, GDNSF is priced at $0.45, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas WLDFF's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -1.54%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, GDNSF is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CBSTF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CBSTF has a market cap of 166.4M. Regarding current trading prices, GDNSF is priced at $0.45, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CBSTF's P/E ratio is -0.23. In terms of profitability, GDNSF's ROE is -1.54%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, GDNSF is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs CRLBF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CRLBF has a market cap of 165.3M. Regarding current trading prices, GDNSF is priced at $0.45, while CRLBF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CRLBF's P/E ratio is -2.04. In terms of profitability, GDNSF's ROE is -1.54%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, GDNSF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.
GDNSF vs BKUH Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BKUH has a market cap of 150.7M. Regarding current trading prices, GDNSF is priced at $0.45, while BKUH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BKUH's P/E ratio is -50.00. In terms of profitability, GDNSF's ROE is -1.54%, compared to BKUH's ROE of +0.10%. Regarding short-term risk, GDNSF and BKUH have similar daily volatility (0.00).
GDNSF vs HUMDF Comparison
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, GDNSF is priced at $0.45, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, GDNSF's ROE is -1.54%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, GDNSF and HUMDF have similar daily volatility (0.00).